CARCINOGEN-INDUCED AMPLIFICATION OF SV40 DNA INSERTED AT 9Q12-21.1 ASSOCIATED WITH CHROMOSOME BREAKAGE, DELETIONS, AND TRANSLOCATIONS IN HUMAN UROEPITHELIAL CELL-TRANSFORMATION IN-VITRO
Ch. Kao et al., CARCINOGEN-INDUCED AMPLIFICATION OF SV40 DNA INSERTED AT 9Q12-21.1 ASSOCIATED WITH CHROMOSOME BREAKAGE, DELETIONS, AND TRANSLOCATIONS IN HUMAN UROEPITHELIAL CELL-TRANSFORMATION IN-VITRO, Genes, chromosomes & cancer, 8(3), 1993, pp. 155-166
The fate of integrated SV40 viral genome in SV40-immortalized human ur
oepithelial cells (SV-HUC) during multistep chemical transformation in
vitro was studied. We previously reported that exposure of SV-HUC at
passage (P) 15 to the chemical carcinogens 3-methylcholanthrene (MCA),
4-aminobiphenyl (ABP), or the N-hydroxy metabolites of ABP causes tum
origenic transformation and/or neoplastic progression. We report now t
hat these same chemical carcinogens induce amplification of SV40 DNA i
n SV-HUC We used fluorescence in situ hybridization (FISH) to show tha
t this amplification occurs at the SV40 integration site, which was ma
pped near a common fragile site at 9q12-21.1 on the der(9)t(8;9) chrom
osome that is present in all SV-HUC at the earliest passage studied. K
aryotypic analysis, along with FISH, also revealed that all carcinogen
-induced tumors (T-SV-HUCs) had breaks at 9q12-21.1, deletions of 9q12
-21.1 --> pter, and new derivative chromosomes containing SV40 in the
segment 9q12-21.1 --> 9q34 = 8q22 --> 8qter. Southern blot analysis, a
long with FISH. confirmed SV40 genome rearrangements in T-SV-HUCs. In
contrast, no 9q12-21.1 breaks were observed in control SV-HUC. Thus, t
hese results associate 9q12-21.1 --> pter alterations with HUC tumorig
enic transformation. In addition, these results indicate for the first
time that (carcinogen-induced) amplification of chromosome-integrated
viral genes may create sites that are prone to breakage, deletions, a
nd translocations. These results suggest a new mechanism by which chem
ical carcinogens in synergy with a DNA tumor virus could initiate a ca
scade of events that contribute to the genomic instability associated
with tumorigenesis. (C) 1993 Wiley-Liss, Inc.